Evaluation of Right Ventricle by Speckle Tracking and Conventional Echocardiography in Rats with Right Ventricular Heart Failure

International Heart Journal

Volumn 56, Issue 3, 2015, Pages 349-353

  Kimura, Koichi ^a   Daimon, Masao ^a   Morita, Hiroyuki ^a   Kawata, Takayuki ^a   Nakao, Tomoko ^a   Okano, Tomoko ^a   Lee, Seitetsu L ^a   Takenaka, Katsu ^b   Nagai, Ryozo ^c   Yatomi, Yutaka ^a   Komuro, Issei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Myocardial performance index; Rodent; Small animal; Tissue Doppler

Indexed keywords

MONOCROTALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; FRACTIONAL AREA CHANGE; HEART PERFORMANCE; HEART RATE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY; SPECKLE TRACKING ECHOCARDIOGRAPHY; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING; TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION; ANIMAL; ECHOCARDIOGRAPHY; HEART FAILURE; HEART VENTRICLE; PATHOPHYSIOLOGY; PROCEDURES; PULMONARY HYPERTENSION; SPRAGUE DAWLEY RAT;

ANIMALS; ECHOCARDIOGRAPHY; HEART FAILURE; HEART VENTRICLES; HEMODYNAMICS; HYPERTENSION, PULMONARY; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84929233601     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.14-367     Document Type: Article

References (19)

1. Csiszar A, Labinskyy N, Olson S, et al. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension 2009; 54: 668-75.
2. Sawamura F, Kato M, Fujita K, Nakazawa T, Beardsworth A. Tadalafil, a long-acting inhibitor of PDE5, improves pulmonary hemodynamics and survival rate of monocrotaline-induced pulmonary artery hypertension in rats. J Pharmacol Sci 2009; 111: 235-43.
3. Mouchaers KT, Schalij I, de Boer MA, et al. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil. Eur Respir J 2010; 36: 800-7.
4. Kimura K, Takenaka K, Pan X, et al. Prediction of coronary artery stenosis using strain imaging diastolic index at rest in patients with preserved ejection fraction. J Cardiol 2011; 57: 311-5.
5. Kimura K, Takenaka K, Ebihara A, et al. Speckle tracking global strain rate E/E’ predicts LV filling pressure more accurately than traditional tissue Doppler E/E’. Echocardiography 2012; 29: 404-10.
6. Koshizuka R, Ishizu T, Kameda Y, Kawamura R, Seo Y, Aonuma K. Longitudinal strain impairment as a marker of the progression of heart failure with preserved ejection fraction in a rat model. J Am Soc Echocardiogr 2013; 26: 316-23.
7. Kimura K, Takenaka K, Ebihara A, et al. Reproducibility and diagnostic accuracy of three-layer speckle tracking echocardiography in a swine chronic ischemia model. Echocardiography 2011; 28: 1148-55.
8. Campian ME, Hardziyenka M, de Bruin K, et al. Early inflammatory response during the development of right ventricular heart failure in a rat model. Eur J Heart Fail 2010; 12: 653-8.
9. Okada M, Harada T, Kikuzuki R, Yamawaki H, Hara Y. Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats. J Pharmacol Sci 2009; 111: 193-200.
10. Gomez-Arroyo JG, Farkas L, Alhussaini AA, et al. The monocrotaline model of pulmonary hypertension in perspective. Am J Physiol Lung Cell Mol Physiol 2012; 302: L363-9. (Review)
11. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685-713.
12. Urboniene D, Haber I, Fang YH, Thenappan T, Archer SL. Validation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2010; 299: L401-12.
13. Redout EM, van der Toorn A, Zuidwijk MJ, et al. Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure. Am J Physiol Heart Circ Physiol 2010; 298: H1038-47.
14. Haeck ML, Scherptong RW, Marsan NA, et al. Prognostic value of right ventricular longitudinal peak systolic strain in patients with pulmonary hypertension. Circ Cardiovasc Imaging 2012; 5: 628-36.
15. Bjornerheim R, Grogaard HK, Kjekshus H, Attramadal H, Smiseth OA. High frame rate Doppler echocardiography in the rat: an evaluation of the method. Eur J Echocardiogr 2001; 2: 78-87.
16. Pirat B, McCulloch ML, Zoghbi WA. Evaluation of global and regional right ventricular systolic function in patients with pulmonary hypertension using a novel speckle tracking method. Am J Cardiol 2006; 98: 699-704.
17. Li Y, Xie M, Wang X, Lu Q, Fu M. Right ventricular regional and global systolic function is diminished in patients with pulmonary arterial hypertension: a 2-dimensional ultrasound speckle tracking echocardiography study. Int J Cardiovasc Imaging 2013; 29: 545-51.
18. Hardegree EL, Sachdev A, Villarraga HR, et al. Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertension. Am J Cardiol 2013; 111: 143-8.
19. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008; 117: 1436-48. (Review)